Latest News Israel

COVIDIEN BUYS SUPERDIMENSION FOR $300M

Share |
Wednesday, April 4th, 2012

Covidien plc (NYSE: COV) will acquire Israel-based bronchial tubes endoscope maker superDimension Ltd. for about $300 million, the company announced in March.  Ireland based-Covidien has annual sales of $30 million.  SuperDimension’s i-Logic System uses Electromagnetic Navigation Bronchoscopy to provide minimally invasive access to lesions in the lungs and is mostly used to diagnose lung cancer.